Focus Partners Advisor Solutions’s SpringWorks Therapeutics SWTX Stock Holding History

Focus Partners Advisor Solutions’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,274	Closed	-$295K	–	1279
2025 Q2	$295K	Buy	6,274 +1,180	+23%	+$52.5K	﹤0.01%	870
2025 Q1	$225K	Buy	+5,094	New	+$234K	﹤0.01%	869

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Focus Partners Advisor Solutions's SWTX Position: Q3 2025 in Review

Focus Partners Advisor Solutions sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 6,274 shares — an estimated $295K sold.

Focus Partners Advisor Solutions first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $295K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Focus Partners Advisor Solutions reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Focus Partners Advisor Solutions sold 6,274 SpringWorks Therapeutics shares in Q3 2025, an estimated $295K.
Focus Partners Advisor Solutions first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Focus Partners Advisor Solutions's SpringWorks Therapeutics position peaked at $295K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Focus Partners Advisor Solutions's 13F filing for Q3 2025, filed 12 Nov 2025.